Safety and Efficacy of PF-06650833, PF-06700841, and PF-06826647 in Adults with Moderate to Severe Hidradenitis Suppurativa. A Phase 2a, Multicenter, Randomized, Double-Blind,
Placebo-Controlled, 16-Week Study Evaluating the Safety and Efficacy of PF-06650833, PF-06700841, and PF-06826647 in Adults with Moderate to Severe Hidradenitis Suppurativa.
Open Plain Language Summary Result:
Click here